Fumarase Human

Fumarate Hydratase Human Recombinant
Cat. No.
BT26018
Source
Escherichia Coli.
Synonyms
MCL, LRCC, HLRCC, MCUL1, FH, Fumarate hydratase, Fumarase.
Appearance
Sterile filtered colorless solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Fumarase Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 467 amino acids (44-510) and having a molecular mass of 50.2 kDa.
Fumarate Hydratase is purified by proprietary chromatographic techniques.

Product Specs

Introduction
Fumarase, a key enzyme in the Krebs cycle, catalyzes the reversible hydration of fumarate to L-malate. This enzyme exists in two forms: a cytosolic form and a mitochondrial form synthesized with an N-terminal extension. The mitochondrial form is transported to the mitochondria, where the N-terminal extension is cleaved, resulting in the same active enzyme as the cytosolic form. Fumarase functions as a homotetramer and shares structural similarities with thermostable Class-2 fumarases. Mutations in the Fumarase gene can lead to fumarase deficiency, a disorder characterized by progressive encephalopathy, cerebral atrophy, and developmental delay. Additionally, Fumarase is recognized for its tumor suppressor role, with mutations in the Fumarase gene linked to Leydig cell tumors, highlighting its significance in adult testicular tumor development.
Description
Recombinant Human Fumarase, expressed in E. coli, is a non-glycosylated polypeptide chain. This single-chain protein consists of 467 amino acids (residues 44-510) and has a molecular weight of 50.2 kDa. The purification process involves proprietary chromatographic methods to ensure high purity.
Physical Appearance
Clear, colorless solution, sterile-filtered.
Formulation
The Fumarase protein solution is provided at a concentration of 1 mg/ml in a buffer containing 20mM Tris-HCl at pH 8.
Stability
For short-term storage (up to 4 weeks), keep refrigerated at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is advised for long-term storage. Minimize repeated freeze-thaw cycles.
Purity
Purity is determined to be greater than 95.0% by SDS-PAGE analysis.
Biological Activity
The specific activity of the enzyme is measured as greater than 25 units/mg. One unit is defined as the amount of enzyme required to convert 1 micromole of L-Malate to Fumarate per minute at a pH of 7.5 and a temperature of 37°C.
Synonyms
MCL, LRCC, HLRCC, MCUL1, FH, Fumarate hydratase, Fumarase.
Source
Escherichia Coli.
Amino Acid Sequence
MASQNSFRIE YDTFGELKVP NDKYYGAQTV RSTMNFKIGG VTERMPTPVI KAFGILKRAA AEVNQDYGLD PKIANAIMKA ADEVAEGKLN DHFPLVVWQT GSGTQTNMNV NEVISNRAIE MLGGELGSKI PVHPNDHVNK SQSSNDTFPT AMHIAAAIEV HEVLLPGLQK LHDALDAKSK EFAQIIKIGR THTQDAVPLT LGQEFSGYVQ QVKYAMTRIK AAMPRIYELA AGGTAVGTGL NTRIGFAEKV AAKVAALTGL PFVTAPNKFE ALAAHDALVE LSGAMNTTAC SLMKIANDIR FLGSGPRSGL GELILPENEP GSSIMPGKVN PTQCEAMTMV AAQVMGNHVA VTVGGSNGHF ELNVFKPMMI KNVLHSARLL GDASVSFTEN CVVGIQANTE RINKLMNESL MLVTALNPHI GYDKAAKIAK TAHKNGSTLK ETAIELGYLT AEQFDEWVKP KDMLGPK.

Product Science Overview

Structure and Function

FH is a homotetrameric enzyme, meaning it consists of four identical subunits. Each subunit has a molecular weight of approximately 50 kDa. The enzyme’s active site is located at the interface between subunits, where it binds to fumarate and catalyzes its conversion to L-malate . The enzyme’s structure has been extensively studied using techniques such as X-ray crystallography, revealing detailed insights into its catalytic mechanism and allosteric regulation .

Genetic and Biochemical Aspects

The FH gene is located on chromosome 1 in humans. Mutations in this gene can lead to fumaric aciduria, a rare metabolic disorder characterized by severe neurological and developmental abnormalities . Biallelic germline mutations in FH result in a deficiency of the enzyme, leading to the accumulation of fumarate in the body .

Role in Disease

FH deficiency is associated with several diseases, including hereditary leiomyomatosis and renal cell carcinoma (HLRCC). In HLRCC, individuals with a single functional copy of the FH gene are predisposed to developing benign smooth muscle tumors (leiomyomas) and aggressive renal cell carcinomas . The loss of FH activity leads to the accumulation of fumarate, which can act as an oncometabolite, promoting tumorigenesis through various mechanisms, including the inhibition of prolyl hydroxylase enzymes and the stabilization of hypoxia-inducible factors .

Recombinant FH

Recombinant FH is produced using genetic engineering techniques, where the human FH gene is cloned and expressed in a suitable host organism, such as Escherichia coli. The recombinant enzyme is then purified for use in research and therapeutic applications. Studies on recombinant FH have provided valuable insights into its structure, function, and role in disease .

Research and Therapeutic Applications

Research on FH has significant implications for understanding metabolic regulation, cancer biology, and potential therapeutic interventions. For instance, pharmacological inhibition or genetic ablation of FH in macrophages has been shown to affect cellular metabolic states and cytokine balance, highlighting its role in immune cell function and inflammation . Additionally, recombinant FH is used in enzyme replacement therapies for treating FH deficiency and related metabolic disorders .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.